Unknown

Dataset Information

0

Bafetinib (INNO-406) reverses multidrug resistance by inhibiting the efflux function of ABCB1 and ABCG2 transporters.


ABSTRACT: ATP-Binding Cassette transporters are involved in the efflux of xenobiotic compounds and are responsible for decreasing drug accumulation in multidrug resistant (MDR) cells. Discovered by structure-based virtual screening algorithms, bafetinib, a Bcr-Abl/Lyn tyrosine kinase inhibitor, was found to have inhibitory effects on both ABCB1- and ABCG2-mediated MDR in this in-vitro investigation. Bafetinib significantly sensitized ABCB1 and ABCG2 overexpressing MDR cells to their anticancer substrates and increased the intracellular accumulation of anticancer drugs, particularly doxorubicin and [(3)H]-paclitaxel in ABCB1 overexpressing cells; mitoxantrone and [(3)H]-mitoxantrone in ABCG2 overexpressing cells, respectively. Bafetinib stimulated ABCB1 ATPase activities while inhibited ABCG2 ATPase activities. There were no significant changes in the expression level or the subcellular distribution of ABCB1 and ABCG2 in the cells exposed to 3??M of bafetinib. Overall, our study indicated that bafetinib reversed ABCB1- and ABCG2-mediated MDR by blocking the drug efflux function of these transporters. These findings might be useful in developing combination therapy for MDR cancer treatment.

SUBMITTER: Zhang YK 

PROVIDER: S-EPMC4860574 | biostudies-literature | 2016 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

Bafetinib (INNO-406) reverses multidrug resistance by inhibiting the efflux function of ABCB1 and ABCG2 transporters.

Zhang Yun-Kai YK   Zhang Guan-Nan GN   Wang Yi-Jun YJ   Patel Bhargav A BA   Talele Tanaji T TT   Yang Dong-Hua DH   Chen Zhe-Sheng ZS  

Scientific reports 20160509


ATP-Binding Cassette transporters are involved in the efflux of xenobiotic compounds and are responsible for decreasing drug accumulation in multidrug resistant (MDR) cells. Discovered by structure-based virtual screening algorithms, bafetinib, a Bcr-Abl/Lyn tyrosine kinase inhibitor, was found to have inhibitory effects on both ABCB1- and ABCG2-mediated MDR in this in-vitro investigation. Bafetinib significantly sensitized ABCB1 and ABCG2 overexpressing MDR cells to their anticancer substrates  ...[more]

Similar Datasets

| S-EPMC6218957 | biostudies-literature
| S-EPMC7694178 | biostudies-literature
| S-EPMC3983711 | biostudies-literature
| S-EPMC6084781 | biostudies-literature
| S-EPMC3078184 | biostudies-literature
| S-EPMC4769028 | biostudies-literature
| S-EPMC4969433 | biostudies-literature
| S-EPMC7226045 | biostudies-literature
| S-EPMC6620786 | biostudies-literature
| S-EPMC8173085 | biostudies-literature